BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 16, 2025
See today's BioWorld
Home
» OncoGenex Trades Discount for Prestige in $50M Offering
To read the full story,
subscribe
or
sign in
.
OncoGenex Trades Discount for Prestige in $50M Offering
March 19, 2012
By
Trista Morrison
No Comments
Shares of OncoGenex Pharmaceuticals Inc. fell 20.8 percent Friday after the Bothell, Wash.-based biotech priced its $50 million public offering at $12 per share.
BioWorld
